Position in GNLX
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$190,186
+$37,279 QoQ
Shares Held
63,185
0.0% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3
of 7 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Falcon Wealth Planning holds $477,545 across 2 Biotechnology names. GNLX ranks #2 (39.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MAZE |
Maze Therapeutics, Inc.
|
9,630 | $287,359 | |
| 2 | GNLX |
GENELUX Corp
This page
|
63,185 | $190,186 |
All Filings in GNLX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $190,186 | 63,185 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $152,907 | 63,185 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $275,486 | 63,185 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $92,400 | 22,000 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $63,140 | 22,000 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $32,400 | 12,000 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $28,320 | 12,000 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $28,440 | 12,000 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $23,400 | 12,000 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $77,160 | 12,000 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $168,120 | 12,000 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $244,900 | 10,000 | Shares | Sole | 2023-10-05 | |
| No filing history on record for this holder in this stock. | ||||||